Thursday, February 17, 2022

New Drug Application for Treatment of Bacterial Vaginosis

Lupin Pharmaceuticals Inc., today announced that the U.S. Food and Drug Administration has approved the company’s supplemental New Drug Application (sNDA) to expand the use of SOLOSEC® (secnidazole) in the treatment of bacterial vaginosis (BV) for female patients 12 years of age and older and in the treatment of trichomoniasis for all patients 12 years […] - Travel News | eTurboNews | eTN

No comments:

Post a Comment